Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.547
Filtrar
4.
Ann Plast Surg ; 93(2S Suppl 1): S47-S50, 2024 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-39101848

RESUMEN

BACKGROUND: Postoperative infection of breast implants can lead to implant removal and other complications. This study aimed to investigate the presence of costal cartilage infection following breast implant surgery and the diagnostic role of PET/CT in identifying this rare complication. PATIENTS AND METHODS: A retrospective study included 16 patients with persistent infections after breast implant removal surgery. Patients underwent PET/CT scans before surgery, and surgical plans were made based on PET/CT findings. Surgical procedures were guided by PET/CT, and specimens were collected for pathological examination and microbiological culture. Follow-up assessments were performed at 1, 3, and 12 months postoperatively. RESULTS: Among the 16 patients, 11 were diagnosed with costal cartilage infection, whereas 5 had subcutaneous soft tissue infections. PET/CT accurately identified costal cartilage infection in all cases and localized the infected costal cartilage in the majority of cases. Microbiological culture results showed various pathogens. All patients were cured with one or staged surgery. CONCLUSION: Costal cartilage infection following breast implant surgery is a significant concern. PET/CT plays a crucial role in the accurate diagnosis and localization of infected costal cartilage, aiding in appropriate surgical management. Patients should be closely monitored for the possibility of costal cartilage infection when experiencing persistent symptoms after breast implant surgery.


Asunto(s)
Implantación de Mama , Implantes de Mama , Cartílago Costal , Tomografía Computarizada por Tomografía de Emisión de Positrones , Humanos , Femenino , Estudios Retrospectivos , Persona de Mediana Edad , Tomografía Computarizada por Tomografía de Emisión de Positrones/métodos , Adulto , Implantes de Mama/efectos adversos , Cartílago Costal/trasplante , Implantación de Mama/efectos adversos , Infecciones Relacionadas con Prótesis/diagnóstico , Infecciones Relacionadas con Prótesis/diagnóstico por imagen , Infecciones Relacionadas con Prótesis/etiología , Infección de la Herida Quirúrgica/diagnóstico , Infección de la Herida Quirúrgica/etiología , Infección de la Herida Quirúrgica/microbiología , Remoción de Dispositivos , Anciano
5.
J Plast Reconstr Aesthet Surg ; 97: 302-309, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39213931

RESUMEN

INTRODUCTION: Indocyanine green (ICG) angiography for the intraoperative evaluation of tissue perfusion is commonly used in implant-based breast reconstruction (IBR). The assessment of ICG images depends on the surgeon's interpretation and is qualitative or semiqualitative in nature. To quantify ICG metrics, this study aimed to apply a novel assessment of fill-rate dynamics to predict wound-healing complications and provide pragmatic assessment tools in IBR. METHODS: This was a retrospective cohort study of patients who underwent IBR with ICG using the photodynamic eye (PDE-Neo II) qualitative imaging system between April 2021 and September 2023. ICG recordings were reviewed to quantify the relative surface area and fluorescence intensity of visual perfusion deficits using ImageJ. The primary outcome was the incidence of wound-healing complications. t-tests and logistic regression were performed for statistical testing. RESULTS: A total of 112 patients (201 breasts) were included. The incidence of wound-healing complications was 12.9%. A higher relative surface area of ischemic regions was significantly associated with wound-healing complications (3.3% vs. 0.90%; p = 0.001). The rate of change in the surface area of ischemic regions was significantly associated with wound-healing complications (0.35% per second vs. 1.29% per second; p = 0.003%). On average, the duration of transient ischemic areas was significantly longer in breasts with wound-healing complications (46.0 s vs. 36.0 s, p = 0.01). CONCLUSION: A transient ischemic area of > 5% of the breast and/or failure to resolve transient ischemic areas after 60 s may predict wound-healing complications and inform surgical reconstructive decision-making in IBR.


Asunto(s)
Verde de Indocianina , Complicaciones Posoperatorias , Cicatrización de Heridas , Humanos , Femenino , Estudios Retrospectivos , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/diagnóstico , Cicatrización de Heridas/fisiología , Colorantes/administración & dosificación , Adulto , Implantación de Mama/métodos , Implantación de Mama/efectos adversos , Angiografía/métodos , Neoplasias de la Mama/cirugía , Mamoplastia/métodos , Mamoplastia/efectos adversos , Implantes de Mama/efectos adversos , Angiografía con Fluoresceína/métodos
6.
Breast ; 77: 103782, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39111201

RESUMEN

INTRODUCTION: Post-mastectomy radiation therapy is an important component of adjuvant therapy for high-risk patients. However, radiation to reconstructed breasts can cause various complications. Recently, hypofractionated (HF) protocols have been adopted in several countries. Here, we aimed to assess the impact of HF protocols on implant-reconstructed breasts through a meta-analysis and systematic review of the currently available literature. METHODS: Records published until August 2023 were systematically searched in PubMed, Cochrane Library, and EMBASE databases. Keywords included hypofractionation radiotherapy, mastectomy, and breast reconstruction. Studies that utilized HF and conventional fractionation (CF) after prosthetic reconstruction were selected. Due to the rarity of events in outcomes, Mantel-Haenszel's odds ratios were calculated using a fixed-effect model to compare the complication rates between HF and CF groups. For analysis with high heterogeneity, a random effect model was used. RESULTS: Seven articles with 924 implant reconstructions, in which 506 (54.8 %) underwent HF were included. HF patients received 43.8 Gy on average, while CF patients received 51.2 Gy. Mean follow-up ranged from 10.6 to 35 months. Seven studies were included in the meta-analysis. HF groups had a significantly lower risk of capsular contracture (OR 0.25, 95 % CI 0.11-0.55), major revision surgery (OR 0.19, 95 % CI 0.05-0.80), and wound dehiscence (OR 0.24, 95 % CI 0.07-0.78) compared to CF groups. The risks of other complications were not statistically significant. CONCLUSION: This study indicates that HF protocols are associated with fewer complications than CF protocols in implant-reconstructed patients. These findings suggest that the application of HF PMRT in implant-reconstructed patients with breast cancer is plausible.


Asunto(s)
Implantación de Mama , Neoplasias de la Mama , Mastectomía , Complicaciones Posoperatorias , Hipofraccionamiento de la Dosis de Radiación , Humanos , Femenino , Neoplasias de la Mama/radioterapia , Neoplasias de la Mama/cirugía , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/epidemiología , Radioterapia Adyuvante/efectos adversos , Radioterapia Adyuvante/métodos , Implantación de Mama/métodos , Implantación de Mama/efectos adversos , Implantes de Mama , Mamoplastia/métodos , Mamoplastia/efectos adversos , Fraccionamiento de la Dosis de Radiación , Persona de Mediana Edad , Adulto
8.
J Plast Reconstr Aesthet Surg ; 96: 107-110, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39084021

RESUMEN

Infection after implant-based breast reconstruction remains challenging, with infection rates up to 24%. Best clinical practice indicates prophylactic oral antibiotics are ineffective at preventing infection. Absorbable antibiotic beads have been routinely used in other surgical subspecialties such as orthopedic and vascular procedures for continuous local antibiotic delivery to the surgical site when implants are placed. Biodegradable calcium sulfate antibiotic beads have been shown to normalize incidence of infection when used prophylactically for a high-risk prepectoral patient population. The purpose of this study is to evaluate the effect of prophylactic biodegradable antibiotic beads when used non-selectively for all prepectoral immediate tissue expander (TE) reconstruction. Patients who underwent mastectomy and immediate prepectoral TE reconstruction on the same day between 2018 and 2024 were reviewed. Patients were divided into two groups: those who received antibiotic beads (Group 1) and those who did not (Group 2). Absorbable calcium-sulfate beads were reconstituted with 1 g vancomycin and 240 mg gentamicin. There were 33 patients (63 TEs) in Group 1 and 330 patients (545 TEs) in Group 2. TE loss was present in 1.5% (1/65 TEs) Group 1 compared to 9.4% (51/545 TEs) in Group 2 (p = 0.032). The mean follow-up time was 178 days (range 93-266 days). Prophylactic biodegradable antibiotic beads used during immediate tissue expander reconstruction decreased implant loss rate. There was one occurrence of SSI in the antibiotic bead group. Antibiotic beads may potentially decrease complications in immediate TE reconstruction when used non-selectively for all patients.


Asunto(s)
Implantes Absorbibles , Antibacterianos , Profilaxis Antibiótica , Gentamicinas , Humanos , Femenino , Persona de Mediana Edad , Antibacterianos/administración & dosificación , Profilaxis Antibiótica/métodos , Gentamicinas/administración & dosificación , Estudios Retrospectivos , Implantes de Mama/efectos adversos , Mastectomía , Sulfato de Calcio/administración & dosificación , Implantación de Mama/métodos , Implantación de Mama/efectos adversos , Vancomicina/administración & dosificación , Adulto , Neoplasias de la Mama/cirugía , Infección de la Herida Quirúrgica/prevención & control , Dispositivos de Expansión Tisular , Expansión de Tejido/métodos , Expansión de Tejido/instrumentación , Infecciones Relacionadas con Prótesis/prevención & control , Infecciones Relacionadas con Prótesis/etiología , Mamoplastia/métodos
10.
Clin Breast Cancer ; 24(7): e613-e621, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39003171

RESUMEN

Breast reconstructive surgery has evolved significantly over the years. One of the recent advancements is the use of prepectoral implants in combination with synthetic and biological material as a natural and effective coverage. To date, there is little published data on breast reconstruction using acellular bovine pericardium matrix and most concern submuscular breast reconstruction. This study aimed to describe the multicentric-multisurgeon experience in performing direct to implant (DTI) prepectoral breast reconstructions using acellular bovine pericardium matrix (ABPM) pocket. A retrospective multicentric data collection of the all the immediate prepectoral breast reconstructions using acellular bovine pericardium was carried out by the authors. Surgical data including type of mastectomy, axillary surgery, type and size of implant, size of ABPM, duration of surgery were collected for each patient. Postoperative data including adjuvant treatments, complications, necessity to perform other interventions, patient's satisfaction were collected. Cosmetic results were also evaluated by 7 different observers at minimum 1 year follow-up. A total of 65 breast reconstruction were included in the study. Mean follow up was 21.3 months. Average surgical time was 1,42 hours. Minor complications occurred in 4 breasts; major complications occurred in 2 breasts. After 6 months follow-up, 7 patients underwent fat grafting to correct any rippling and /or wrinkling. Breast aesthetic and patients reported outcomes were satisfactory. Not significant capsular contracture was noted at the follow up control. To date, this is the largest study about prepectoral breast reconstruction with ABPM. On the basis of our results, prepectoral breast reconstruction ABPM assisted is a reliable, safe and suitable option providing good patient satisfaction outcomes.


Asunto(s)
Neoplasias de la Mama , Mastectomía , Pericardio , Humanos , Femenino , Pericardio/trasplante , Estudios Retrospectivos , Neoplasias de la Mama/cirugía , Neoplasias de la Mama/patología , Persona de Mediana Edad , Bovinos , Animales , Adulto , Mastectomía/métodos , Satisfacción del Paciente , Mamoplastia/métodos , Implantes de Mama , Implantación de Mama/métodos , Implantación de Mama/instrumentación , Implantación de Mama/efectos adversos , Estudios de Seguimiento , Anciano , Complicaciones Posoperatorias/etiología
11.
Clin Breast Cancer ; 24(7): 604-610, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39019728

RESUMEN

PURPOSE: The Area Deprivation Index (ADI) ranks neighborhoods by deprivation based on US Census data. This study utilizes ADI scores to investigate the impact of neighborhood deprivation on complication rates following breast reconstruction. PATIENTS AND METHODS: Patients who received implant-based reconstruction from 2019 to 2023 were identified at a single institution in New York. Patients were linked to a state-specific ADI score and categorized into groups: "High ADI" (6-10) and "Low ADI" (1-5). Patient characteristics and complication rates were compared between the ADI groups with Chi-Square analysis and t-tests. The predictive value of ADI scores on complication rates was assessed using logistic regression models. RESULTS: In total, 471 patients were included, of which 16% (n = 73) were in the High ADI group, and 84% (n = 398) were in the Low ADI group. There were no baseline differences between the 2 groups, except that there were more patients of Hispanic descent in the High ADI group (30% vs. 15%, P < .01). The High ADI group had a higher overall complication rate than the Low ADI group (34% vs. 21%, P < .01), as well as higher individual rates of hematoma (12% vs. 3%, P < .01) and unexpected reoperations (18% vs. 7%, P < .01). After adjusting for differences in race, High ADI scores predicted hematoma, reoperations, and any complication (P < .05). CONCLUSION: Patients living in neighborhoods with high ADI had a higher incidence of postoperative complications, independent of comorbidities and race. This measure of disparity should be considered when counselling patients about their risk of complications following procedures like implant-based breast reconstruction.


Asunto(s)
Implantación de Mama , Neoplasias de la Mama , Complicaciones Posoperatorias , Humanos , Femenino , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Persona de Mediana Edad , Neoplasias de la Mama/cirugía , Implantación de Mama/efectos adversos , Adulto , Implantes de Mama/efectos adversos , Características de la Residencia/estadística & datos numéricos , New York/epidemiología , Características del Vecindario/estadística & datos numéricos , Estudios Retrospectivos , Mamoplastia/efectos adversos , Mamoplastia/estadística & datos numéricos , Factores de Riesgo
14.
J Plast Reconstr Aesthet Surg ; 95: 402-410, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-39047335

RESUMEN

BACKGROUND: In immediate breast reconstruction (IBR), it is unclear whether there is any difference in the complication rates between prepectoral versus subpectoral implant placement without acellular dermal matrix (ADM). AIM: To compare the rates of early post-operative complications and time to initiation of adjuvant treatment in patients undergoing IBR between prepectoral and subpectoral implant placement without ADM for the two surgical procedure. METHODS: We retrospectively retrieved data of patients who underwent IBR with prepectoral versus subpectoral implant placement between January 1, 2020 and December 31, 2022 in a large cancer center in France. RESULTS: We included 192 patients: 119 in the prepectoral and 73 in the subpectoral group. Their clinical characteristics were similar. Thirty patients (15.6%) received adjuvant chemotherapy, among them 27 (14.1%) received it within 12 weeks, and there was no difference between the groups (p = 0.12). In the prepectoral group, 39 patients (32.8%) received adjuvant radiotherapy versus 5 (6.8%) in the subpectoral group (p < 0.001), but there was no significant difference in time to treatment commencement. Overall, 35 patients (29.4%) in the prepectoral group and 17 (23.3%) in the subpectoral group experienced post-operative complications (p = 0.44). Using multivariable analysis, the only factor associated with post-operative complications was determined to be mastectomy weight (odds ratio 1.98 (1.10-3.59) for weight ≥500 g; p = 0.02). CONCLUSION: Prepectoral implant placement without ADM can be proposed to patients undergoing IBR with an indication for adjuvant treatment. However, in our study, the reoperation rate with this technique was slightly higher (p = 0.008). This is partly due to the learning curve for surgeons using this new technique.


Asunto(s)
Dermis Acelular , Implantación de Mama , Neoplasias de la Mama , Complicaciones Posoperatorias , Humanos , Femenino , Persona de Mediana Edad , Estudios Retrospectivos , Complicaciones Posoperatorias/etiología , Neoplasias de la Mama/cirugía , Implantación de Mama/métodos , Implantación de Mama/efectos adversos , Quimioterapia Adyuvante , Radioterapia Adyuvante , Músculos Pectorales/cirugía , Implantes de Mama/efectos adversos , Adulto , Mastectomía/efectos adversos , Mamoplastia/métodos , Mamoplastia/efectos adversos
15.
J Plast Reconstr Aesthet Surg ; 95: 368-376, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38986311

RESUMEN

INTRODUCTION: Considerable research has been carried out on the postoperative benefits of extended antibiotic prophylaxis (EAP) in different surgical contexts, generating various results regarding its effectiveness. Some studies indicate positive outcomes, whereas others indicate no significant advantages. Our approach involves conducting a comprehensive systematic review and meta-analysis to provide a more nuanced understanding of the role of extended antibiotic use because of the lack of a consistent consensus. METHODS: A thorough search of the Cochrane Library, Embase, and MEDLINE electronic databases was conducted to identify relevant studies. The metafor package in R software was used for meta-analysis. We collected risk ratios (RRs) for surgical site infection (SSI) in the EAP versus non-EAP groups from the included studies to assess the effects of EAP on reducing the risk of SSI. The meta-analysis used a random-effects model, and effect sizes were presented with their corresponding 95% confidence intervals (CIs). RESULTS: Fourteen studies, involving 12,572 patients who underwent implant-based reconstruction postmastectomy, were included. Pooling the results of the studies that used EAP until drain removal revealed no protective effect of EAP against SSI risk (RR = 0.84; 95% CI: 0.60-1.18). Similarly, our analysis revealed no significant benefit of EAP in studies where EAP was not contingent on drain removal (RR = 0.70; 95% CI: 0.46-1.07). CONCLUSIONS: EAP administration did not decrease the incidence of SSI in individuals undergoing implant-based breast reconstruction surgery postmastectomy.


Asunto(s)
Profilaxis Antibiótica , Implantación de Mama , Infección de la Herida Quirúrgica , Humanos , Profilaxis Antibiótica/métodos , Infección de la Herida Quirúrgica/prevención & control , Femenino , Implantación de Mama/métodos , Implantación de Mama/efectos adversos , Antibacterianos/administración & dosificación , Implantes de Mama/efectos adversos , Mamoplastia/métodos , Mamoplastia/efectos adversos , Mastectomía , Neoplasias de la Mama/cirugía
17.
Aesthet Surg J ; 44(9): NP639-NP644, 2024 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-38825810

RESUMEN

Breast augmentation is the most commonly performed aesthetic surgery procedure in women worldwide. The use of the subfascial plane has been suggested to decrease the incidence of capsular contracture compared with the subglandular plane, while simultaneously avoiding the complication of animation deformity in the subpectoral plane. The aim of this systematic review and meta-analysis was to compare the adverse outcomes of subfascial vs subglandular planes in breast augmentation. This review was registered a priori on OSF (https://osf.io/pm92e/). A search from inception to June 2023 was performed on MEDLINE, Embase, and CENTRAL. A hand search was also performed. All randomized and comparative cohort studies that assessed the use of the subfascial plane for breast augmentation were included. Outcomes evaluated included the incidences of seroma, hematoma, infection, rippling, capsular contracture, and revision surgery. Ten studies were included in this systematic review. Three randomized controlled trials and 7 comparative cohort studies were used for quantitative synthesis. There was a significant difference favoring subfascial compared with subglandular planes in the incidence of hematoma, rippling, and capsular contracture. All included studies had a high risk of bias. The current evidence suggests that the subfascial plane for breast augmentation decreases the risk of capsular contracture, hematoma, and rippling compared with the subglandular plane. Further randomized evidence with high methodological rigor is still required to validate these findings.


Asunto(s)
Implantación de Mama , Complicaciones Posoperatorias , Humanos , Femenino , Implantación de Mama/métodos , Implantación de Mama/efectos adversos , Implantación de Mama/instrumentación , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/prevención & control , Resultado del Tratamiento , Ensayos Clínicos Controlados Aleatorios como Asunto , Fasciotomía/métodos , Fasciotomía/efectos adversos , Contractura Capsular en Implantes/epidemiología , Contractura Capsular en Implantes/etiología , Contractura Capsular en Implantes/prevención & control , Implantes de Mama/efectos adversos , Reoperación/estadística & datos numéricos , Mamoplastia/métodos , Mamoplastia/efectos adversos , Seroma/etiología , Seroma/epidemiología , Seroma/prevención & control
19.
Clin Lymphoma Myeloma Leuk ; 24(9): e293-e300, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38839449

RESUMEN

Breast implant insertion for breast reconstruction or breast augmentation is a developing procedure, with high demand worldwide-being the second most common plastic surgery in the US as of 2022. Breast-implant-associated anaplastic large cell lymphoma (BIA-ALCL) is T-cell, non-Hodgkin lymphoma, typically CD30+, ALK-, presenting with fluid collection in the inner aspect of the peri-implant capsule in most patients, with the onset exceeding 1-year after implantation. The mean time between breast implant insertion and BIA-ALCL development is 7-10 years. The main risk factor is the use of textured implants because of their susceptibility to triggering local inflammation and immune stimulation finally leading to lymphoproliferation. Genetic predispositions to hereditary breast cancer increase the risk of disease development as well. BIA-ALCL seems to be underestimated in many countries and the initial symptom-seroma might be overlooked and misdiagnosed. Despite its rarity, the awareness of the disease should be improved among patients and medical professionals. This paper summarizes epidemiology, etiopathogenesis, differential diagnosis, and treatment-both surgical and hematological approaches.


Asunto(s)
Implantes de Mama , Linfoma Anaplásico de Células Grandes , Humanos , Linfoma Anaplásico de Células Grandes/etiología , Implantes de Mama/efectos adversos , Femenino , Neoplasias de la Mama/etiología , Cirugía Plástica , Implantación de Mama/efectos adversos , Hematología/métodos , Factores de Riesgo
20.
Aesthet Surg J ; 44(10): NP695-NP710, 2024 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-38857184

RESUMEN

BACKGROUND: A subset of females with breast implants have reported a myriad of nonspecific systemic symptoms collectively termed systemic symptoms associated with breast implants (SSBI). SSBI symptoms are similar to manifestations associated with autoimmune and connective tissue disorders. Breast tissue is rich in adipose cells, comprised of lipids. Insertion of an implant creates an oxidative environment leading to lipid oxidation. Oxylipins can influence immune responses and inflammatory processes. OBJECTIVES: In this study we explored the abundance of a spectrum of oxylipins in the periprosthetic tissue surrounding the breast implant. Because oxylipins are immunogenic, we sought to determine if they were associated with the SSBI patients. We have also attempted to determine if the common manifestations exhibited by such patients have any association with oxylipin abundance. METHODS: The study included 120 patients divided into 3 cohorts. We analyzed 46 patients with breast implants exhibiting manifestations associated with SSBI; 29 patients with breast implants not exhibiting manifestations associated with SSBI (control cohort I, non-SSBI); and 45 patients without implants (control cohort II, no-implant tissue). Lipid extraction and oxylipin quantification were performed with liquid chromatography mass spectrometry (LC-MS/MS). LC-MS/MS targeted analysis of the breast adipose tissue was performed. RESULTS: Of the 15 oxylipins analyzed, 5 exhibited increased abundance in the SSBI cohort when compared to the non-SSBI and no-implant cohorts. CONCLUSIONS: The study documents the association of the oxylipins with each manifestation reported by the patient. This study provides an objective assessment of the subjective questionnaire, highlighting which symptoms may be more relevant than the others.


Asunto(s)
Implantes de Mama , Oxilipinas , Humanos , Femenino , Implantes de Mama/efectos adversos , Oxilipinas/análisis , Oxilipinas/metabolismo , Persona de Mediana Edad , Adulto , Implantación de Mama/efectos adversos , Espectrometría de Masas en Tándem , Tejido Adiposo/metabolismo , Anciano , Cromatografía Liquida , Mama/cirugía , Estudios de Casos y Controles
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA